Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension
- Author
- GOMBERG-MAITLAND, Mardi; TAPSON, Victor F; BENZA, Raymond L; MCLAUGHLIN, Vallerie V; KRICHMAN, Abigail; WIDLITZ, Allison C; BARST, Robyn J
Columbia University College of Physicians and Surgeons, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
University of Alabama, Birmingham, Alabama, United States
University of Chicago Hospitals, Chicago, Illinois, United States
University of Michigan, Ann Arbor, Michigan, United States - Source
American journal of respiratory and critical care medicine. 2005, Vol 172, Num 12, pp 1586-1589, 4 p ; ref : 13 ref
- ISSN
- 1073-449X
- Scientific domain
- Pneumology
- Publisher
- American Lung Association, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- epoprostenol intravenous treprostinil pulmonary arterial hypertension
- Keyword (fr)
- Epoprosténol Hypertension artérielle pulmonaire Inhibiteur thromboagrégation Réanimation Soin intensif Transition Tréprostinil Vasodilatateur Voie intraveineuse Prostacycline Appareil circulatoire pathologie Appareil respiratoire pathologie Arachidonique acide dérivé Prostaglandine I2 Prostaglandine dérivé
- Keyword (en)
- Epoprostenol Pulmonary hypertension Antiplatelet agent Resuscitation Intensive care Transition Treprostinil Vasodilator agent Intravenous administration Cardiovascular disease Respiratory disease Arachidonic acid derivatives Prostaglandin I2 Prostaglandin derivatives
- Keyword (es)
- Epoprostenol Hipertensión arterial pulmonar Inhibidor tromboagregación Reanimación Cuidado intensivo Transición Treprostinilo Vasodilatador Vía intravenosa Aparato circulatorio patología Aparato respiratorio patología Araquidónico ácido derivado Prostaglandina I2 Prostaglandina derivado
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11C Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B05 Arterial hypertension. Arterial hypotension / 002B12B05B Clinical manifestations. Epidemiology. Investigative techniques. Etiology
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27B Intensive care medicine
- Discipline
- Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy Cardiology. Circulatory system Pulmonology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17338711
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1164/rccm.200505-766OC 
https://dx.doi.org/10.1164/rccm.200505-766OC
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1164\/rccm.200505-766OC\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:94:\"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension\";s:9:\"\u0000*\u0000jtitle\";s:58:\"American journal of respiratory and critical care medicine\";s:9:\"\u0000*\u0000stitle\";s:29:\"Am. j. respir. crit. care med\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"172\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1586\";s:8:\"\u0000*\u0000epage\";s:4:\"1589\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1073-449X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"GOMBERG-MAITLAND\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Mardi\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:16:\"TAPSON, Victor F\";i:1;s:16:\"BENZA, Raymond L\";i:2;s:22:\"MCLAUGHLIN, Vallerie V\";i:3;s:17:\"KRICHMAN, Abigail\";i:4;s:18:\"WIDLITZ, Allison C\";i:5;s:14:\"BARST, Robyn J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:94:\"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:25:\"American Lung Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1164\/rccm.200505-766OC\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:94:\"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension\";s:9:\"\u0000*\u0000jtitle\";s:58:\"American journal of respiratory and critical care medicine\";s:9:\"\u0000*\u0000stitle\";s:29:\"Am. j. respir. crit. care med\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"172\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1586\";s:8:\"\u0000*\u0000epage\";s:4:\"1589\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1073-449X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"GOMBERG-MAITLAND\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Mardi\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:16:\"TAPSON, Victor F\";i:1;s:16:\"BENZA, Raymond L\";i:2;s:22:\"MCLAUGHLIN, Vallerie V\";i:3;s:17:\"KRICHMAN, Abigail\";i:4;s:18:\"WIDLITZ, Allison C\";i:5;s:14:\"BARST, Robyn J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:94:\"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:25:\"American Lung Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1164\/rccm.200505-766OC\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1164\/rccm.200505-766OC\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:94:\"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension\";s:9:\"\u0000*\u0000jtitle\";s:58:\"American journal of respiratory and critical care medicine\";s:9:\"\u0000*\u0000stitle\";s:29:\"Am. j. respir. crit. care med\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"172\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1586\";s:8:\"\u0000*\u0000epage\";s:4:\"1589\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1073-449X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"GOMBERG-MAITLAND\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Mardi\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:16:\"TAPSON, Victor F\";i:1;s:16:\"BENZA, Raymond L\";i:2;s:22:\"MCLAUGHLIN, Vallerie V\";i:3;s:17:\"KRICHMAN, Abigail\";i:4;s:18:\"WIDLITZ, Allison C\";i:5;s:14:\"BARST, Robyn J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:94:\"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:25:\"American Lung Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1164\/rccm.200505-766OC\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:94:\"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension\";s:9:\"\u0000*\u0000jtitle\";s:58:\"American journal of respiratory and critical care medicine\";s:9:\"\u0000*\u0000stitle\";s:29:\"Am. j. respir. crit. care med\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"172\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1586\";s:8:\"\u0000*\u0000epage\";s:4:\"1589\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1073-449X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"GOMBERG-MAITLAND\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Mardi\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:16:\"TAPSON, Victor F\";i:1;s:16:\"BENZA, Raymond L\";i:2;s:22:\"MCLAUGHLIN, Vallerie V\";i:3;s:17:\"KRICHMAN, Abigail\";i:4;s:18:\"WIDLITZ, Allison C\";i:5;s:14:\"BARST, Robyn J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:94:\"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:25:\"American Lung Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1164\/rccm.200505-766OC\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:94:\"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension\";s:9:\"\u0000*\u0000jtitle\";s:58:\"American journal of respiratory and critical care medicine\";s:9:\"\u0000*\u0000stitle\";s:29:\"Am. j. respir. crit. care med\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"172\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1586\";s:8:\"\u0000*\u0000epage\";s:4:\"1589\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1073-449X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"GOMBERG-MAITLAND\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Mardi\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:16:\"TAPSON, Victor F\";i:1;s:16:\"BENZA, Raymond L\";i:2;s:22:\"MCLAUGHLIN, Vallerie V\";i:3;s:17:\"KRICHMAN, Abigail\";i:4;s:18:\"WIDLITZ, Allison C\";i:5;s:14:\"BARST, Robyn J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:94:\"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:25:\"American Lung Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
